ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.08
0.12%
Dow Jones
38,930.29
0.20%
US Dollar vs MXN
16.8598
-0.15%
Brent Oil
82.605
-1.04%
Bitcoin
63,277.36
0.19%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ChromaDex Corporation (CDXC)

  7. ChromaDex Corporation (CDXC) Noticias

CDXC ChromaDex Corporation

3.84
0.04 (1.05%)
Última actualización: 08:48:07
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ChromaDex Corporation CDXC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.04 1.05% 3.84 08:48:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.85 3.80 3.872 3.80
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202407:32BWChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR),..
25/4/202407:34BWChromaDex Announces Nationwide Launch of Tru Niagen® at The..
24/4/202407:34BWChromaDex to Report First Quarter 2024 Financial Results on..
23/4/202407:32BWChromaDex Announces Inaugural Major Grocery Debut of Tru..
26/3/202407:32BWChromaDex Announces Tru Niagen® is Now Third-Party Verified..
06/3/202415:04BWChromaDex Corporation Reports Fourth Quarter and Fiscal Year..
06/3/202415:02EDGAR2Form 8-K - Current report
06/3/202415:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202419:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202407:32BWChromaDex to Report Fourth Quarter 2023 Financial Results on..
05/2/202407:32BWChromaDex to Participate in Renmark’s Virtual Non-Deal..
26/1/202415:08BWChromaDex to Present at the Lytham Partners 2024 Investor..
20/12/202308:04BWChromaDex Supports the US Military with its Industry Leading..
13/12/202315:00EDGAR2Form 8-K - Current report
12/12/202309:30PRNUSNeurohacker Collective and ChromaDex Partner to Optimize..
04/12/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202307:34BWA Milestone Phase I Randomized, Double-Blind Clinical Trial..
15/11/202307:32BWNewly Published Phase II Clinical Study Demonstrates that..
09/11/202307:32BWChromaDex to Participate in Renmark’s Virtual Non-Deal..
08/11/202315:02EDGAR2Form 8-K - Current report
08/11/202315:02BWChromaDex Corporation Reports Third Quarter 2023 Financial..
08/11/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202307:34BWChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg..
31/10/202307:34BWChromaDex to Report Third Quarter 2023 Financial Results on..
26/10/202307:32BWChromaDex and Zesty Paws® Crack the Code on Cellular Health..
02/10/202307:32BWA Milestone Clinical Study Reveals that Elevating..
07/9/202305:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202305:20EDGAR2Form SC 13D/A - General statement of acquisition of..
24/8/202307:32BWPreclinical Study Builds on Growing Body of Evidence..
15/8/202320:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:02EDGAR2Form 8-K - Current report
09/8/202315:02BWChromaDex Corporation Reports Second Quarter 2023 Financial..
09/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202307:34BWChromaDex Launches Tru Niagen® with iHerb, the World’s..
07/8/202307:32BWChromaDex to Participate in Renmark’s Virtual Non-Deal..
02/8/202307:02BWChromaDex to Report Second Quarter 2023 Financial Results on..
18/7/202307:32BWFindings from Published Abstracts Showcase the Importance of..
06/7/202315:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/7/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
16/6/202307:32BWChromaDex, a Global Authority on Nicotinamide Adenine..
30/5/202307:34BWChromaDex to Participate in the LD Micro Invitational XIII
11/5/202307:34BWChromaDex to Present at the Lytham Partners Spring 2023..
10/5/202315:02BWChromaDex Corporation Reports First Quarter 2023 Financial..

Su Consulta Reciente

NASDAQ
CDXC
ChromaDex
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados